Jacobs Levy Equity Management, Inc Ardelyx, Inc. Transaction History

Jacobs Levy Equity Management, Inc

$24.7 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.65 - $1.18 $1.62 Million - $2.94 Million	-2,492,294 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$0.86 - $1.7 $1.73 Million - $3.42 Million	2,012,348 Added 419.29%	2,492,294 $2.74 Million
Q3 2021 Nov 15, 2021	SELL	$1.27 - $8.17 $125,855 - $809,638	-99,099 Reduced 17.11%	479,946 $634,000
Q2 2021 Aug 16, 2021	SELL	$6.55 - $8.98 $2.74 Million - $3.76 Million	-418,901 Reduced 41.98%	579,045 $4.39 Million
Q1 2021 May 17, 2021	BUY	$6.1 - $7.69 $2.86 Million - $3.61 Million	468,833 Added 88.61%	997,946 $6.61 Million
Q4 2020 Feb 16, 2021	BUY	$5.05 - $7.1 $2.6 Million - $3.66 Million	515,513 Added 3790.54%	529,113 $3.42 Million
Q3 2020 Nov 16, 2020	SELL	$5.25 - $7.08 $236,964 - $319,562	-45,136 Reduced 76.85%	13,600 $71,000
Q1 2020 May 15, 2020	SELL	$4.35 - $8.79 $4,785 - $9,668	-1,100 Reduced 1.84%	58,736 $334,000
Q4 2019 Feb 14, 2020	SELL	$4.23 - $8.29 $94,853 - $185,894	-22,424 Reduced 27.26%	59,836 $449,000
Q3 2019 Nov 14, 2019	BUY	$2.15 - $6.28 $96,859 - $282,920	45,051 Added 121.08%	82,260 $387,000
Q2 2019 Aug 13, 2019	SELL	$2.49 - $3.73 $101,567 - $152,146	-40,790 Reduced 52.3%	37,209 $100,000
Q1 2019 May 14, 2019	SELL	$1.88 - $3.35 $40,636 - $72,410	-21,615 Reduced 21.7%	77,999 $218,000
Q4 2018 Feb 14, 2019	BUY	$1.66 - $4.16 $25,564 - $64,064	15,400 Added 18.29%	99,614 $178,000
Q3 2018 Nov 14, 2018	SELL	$3.75 - $4.65 $129,000 - $159,960	-34,400 Reduced 29.0%	84,214 $366,000
Q2 2018 Aug 14, 2018	BUY	$3.7 - $5.8 $87,320 - $136,880	23,600 Added 24.84%	118,614 $439,000
Q1 2018 May 15, 2018	BUY	$5.05 - $7.9 $59,590 - $93,220	11,800 Added 14.18%	95,014 $480,000
Q4 2017 Feb 13, 2018	BUY	$4.85 - $7.8 $212,429 - $341,640	43,800 Added 111.13%	83,214 $549,000
Q3 2017 Nov 14, 2017	BUY	$4.35 - $5.7 $171,450 - $224,659	39,414	39,414 $221,000

Others Institutions Holding ARDX

# of Institutions

218

Shares Held

141M

Call Options Held

1.08M

Put Options Held

View Full List

About ARDELYX, INC.

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $799M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

More about ARDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Account